Lupin
Dania Bellan currently serves as Vice President of Portfolio & Business Development EMEA at Lupin, a position held since April 2024. Prior to this, Dania was the Global Head of Future Portfolio & Business Innovation at Abbott from October 2022 to January 2024. With extensive experience at Sandoz from November 2010 to September 2022, Dania held multiple roles including Head of Portfolio Sandoz International Region and Customer Marketing Head, focusing on product launches and strategic planning across Western Europe. Dania's career also includes positions at TEVA ITALIA and TEVA EUROPE, where responsibilities encompassed portfolio management and business development. Dania's educational background includes a degree in political sciences and various certifications from prestigious institutions, including Harvard Business School.
This person is not in any teams
This person is not in any offices
Lupin
15 followers
Lupin is a global pharmaceutical company offering Branded and Generic Formulations, Biosimilars and Active Pharmaceutical Ingredients (APIs). Founded over 50 years ago, Lupin today is a significant player in the US, India and Japan and additionally in other counties within APAC, EMEA and LATAM. It holds a global leadership position in Anti-TB and Cephalosporin segments.